Request Sample Inquiry
Neurostimulation Devices Market

Neurostimulation Devices Market

Neurostimulation Devices Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:


Base Year:



Sep - 2022



Report Code:


Segments Covered
  • By Product Type By Product Type Spinal Cord Stimulators, Deep Brain Stimulators, Cochlear Implants, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Percutaneous Tibial Nerve Stimulators, Transcranial Magnetic Stimulators
  • By Application By Application Chronic Pain, Movement Disorders, Hearing Impairment, Epilepsy, Urinary Incontinence, Other Applications
  • By End Users By End Users Hospitals, Ambulatory Surgery Centers, Specialty Clinics
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 4.49 Billion
Revenue 2030Revenue 2030: USD 11.26 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 12.20%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Neurostimulation Devices Market by Product Type by Application by End Users by Region - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Neurostimulation Devices supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:

  • Neurostimulation Devices market size at regional and country level
  • Key industry players and their market share and Neurostimulation Devices market-specific sales/revenue
  • Understanding of the Neurostimulation Devices supply chain and overall ecosystem

Data Triangulation and Market Size Estimations

After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Neurostimulation Devices market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market.  The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Neurostimulation Devices market. 

Frequently Asked Question
  • The global Neurostimulation Devices valued at USD 4.49 Billion in 2022 and is expected to reach USD 11.26 Billion in 2030 growing at a CAGR of 12.20%.

  • The prominent players in the market are Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., LivaNova PLC, Axonics Modulation Technologies Inc., Neuropace Inc., EndoStimInc., NDI Medical, Cochlear Limited, Neuronetics Inc..

  • The market is project to grow at a CAGR of 12.20% between 2023 and 2030.

  • The driving factors of the Neurostimulation Devices include

    • Rise in prevalence of neurological disorders

  • North America was the leading regional segment of the Neurostimulation Devices in 2022.

Related Reports